UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

The Lancet (British edition), 2013-06, Vol.381 (9883), p.2109-2117

2013

Volltextzugriff (PDF)

Immunoterapia del cancro: Immunoterapia del cancro

Global & regional health technology assessment (Online), 2019-10, Vol.3 (Suppl. 1), p.S1-S2

Vella, Stefano

2019

Volltextzugriff (PDF)

Beyond viral suppression of HIV - the new quality of life frontier

BMC medicine, 2016-06, Vol.14 (1), p.94-94, Article 94

2016

Volltextzugriff (PDF)

From HIV to global health

Journal of Virus Eradication, 2018-05, Vol.4, p.1

Vella, Stefano

2018

Volltextzugriff (PDF)

A brief history of antiretroviral therapy of HIV infection: success and challenges

Annali dell'Istituto superiore di sanità, 2011, Vol.47 (1), p.44-48

2011

Volltextzugriff (PDF)

The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort study

BMC infectious diseases, 2024-09, Vol.24 (1), p.901-12, Article 901

2024

Volltextzugriff (PDF)

Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases

BMC medicine, 2013-01, Vol.11 (1), p.4-4, Article 4

2013

Volltextzugriff (PDF)

Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8 + T lymphocyte exhaustion

BMC biotechnology, 2019-10, Vol.19 (1), p.67-67, Article 67

2019

Volltextzugriff (PDF)

Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity

BMC biotechnology, 2019-09, Vol.19 (1), p.64-12, Article 64

2019

Volltextzugriff (PDF)

Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery

PloS one, 2013-07, Vol.8 (7), p.e68950

2013

Volltextzugriff (PDF)

Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study

PloS one, 2015-09, Vol.10 (9), p.e0136117-e0136117

2015

Volltextzugriff (PDF)

Changing incidence of central nervous system diseases in the EuroSIDA cohort

Annals of neurology, 2004-03, Vol.55 (3), p.320-328

2004

Volltextzugriff (PDF)

APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz

Frontiers in immunology, 2018-08, Vol.9, p.1839-1839

2018

Volltextzugriff (PDF)

The reverse transcription inhibitor abacavir shows anticancer activity in prostate cancer cell lines

PloS one, 2010-12, Vol.5 (12), p.e14221

2010

Volltextzugriff (PDF)

The effect of sex/gender on cardiovascular pharmacology

Current pharmaceutical design, 2011-04, Vol.17 (11), p.1095-1107

2011

Volltextzugriff (PDF)

HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS

Current HIV research, 2011-04, Vol.9 (3), p.148-153

2011

Volltextzugriff (PDF)

Epidemiological and economic evaluations according to DAA treatment access: an interim evaluation based on PITER cohort data

Journal of Virus Eradication, 2018-05, Vol.4, p.25-26

2018

Volltextzugriff (PDF)

End of AIDS on the horizon, but innovation needed to end HIV

The lancet HIV, 2015-03, Vol.2 (3), p.e74-e75

Vella, Stefano

2015

Volltextzugriff (PDF)

In memoriam: Joep Lange MD, PhD

Journal of the International AIDS Society, 2014-01, Vol.17 (1), p.19401-n/a

2014

Volltextzugriff (PDF)

Addressing barriers to the end of AIDS by 2030

The lancet HIV, 2015-09, Vol.2 (9), p.e360-e361

Vella, Stefano

2015

Volltextzugriff (PDF)

Glances in Immunology of HIV and HCV Infection

Advances in Virology, 2012-01, Vol.2012 (2012), p.112-124

2012

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(295)
Mit Volltextzugriff
(265)

Publikationsform

Sprache

Englisch
(329)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

Immunoterapia del cancro: Immunoterapia del cancro

Beyond viral suppression of HIV - the new quality of life frontier

From HIV to global health

A brief history of antiretroviral therapy of HIV infection: success and challenges

The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort study

Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases

Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8 + T lymphocyte exhaustion

Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery

Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study

Changing incidence of central nervous system diseases in the EuroSIDA cohort

Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial

APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz

The reverse transcription inhibitor abacavir shows anticancer activity in prostate cancer cell lines

The effect of sex/gender on cardiovascular pharmacology

Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS

Epidemiological and economic evaluations according to DAA treatment access: an interim evaluation based on PITER cohort data

End of AIDS on the horizon, but innovation needed to end HIV

In memoriam: Joep Lange MD, PhD

Addressing barriers to the end of AIDS by 2030

Glances in Immunology of HIV and HCV Infection

Suchergebnisse filtern